Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20.012
Filtrar
1.
Acta Biomed ; 92(1): e2021105, 2021 02 16.
Artículo en Inglés | MEDLINE | ID: mdl-33682810

RESUMEN

The pandemic caused by SARS-CoV2 has stressed health care systems worldwide. The high volume of patients, combined with an increased need for intensive care and potential transmission, has forced reorganization of hospitals and care delivery models. In this article, are presented approaches to minimize risk to Otolaryngologists during their patients infected with COVID-19 care. We performed a narrative literature review among PubMed, Scopus and Web of Science electronic databases, searching for studies on SARS-CoV2 and Risk Management. Standard operating procedures have been adapted both for facilities and for health care workers, including the development of well-defined and segregated patient care areas for treating those affected by COVID-19. Personal protective equipment (PPEs) availability and adequate healthcare providers training on their use should be ensured. Preventive measures are especially important in Otolaryngology-Head and Neck Surgery, as the exposure to saliva suspensions, droplets and aerosols are increased in the upper aero-digestive tract routine examination. Morever, the frequent invasive procedures, such as laryngoscopy, intubation or tracheotomy placement and care, represent a high risk of contracting COVID-19.


Asunto(s)
/prevención & control , Otorrinolaringólogos , Gestión de Riesgos , Humanos , Equipo de Protección Personal , Traqueostomía
2.
Acute Med ; 20(1): 2-3, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33749688

RESUMEN

In February 2021 Jon Hilton (AIM ST4 doctor) published a tweet asking about how the Acute Medicine community can best address potential applicant's fears of dealing with clinical risk. Appraising and managing risk is at the core of acute medical clinical practice; we treat patients in the first crucial 24 hours of their hospital journey, when the clinical status is changeable, and the clinical trajectory not yet established. We make judgement calls about medical treatment, but also about whether a patient can be safely discharged home, and this often causes anxiety amongst less experienced clinicians: how do you make that call?


Asunto(s)
Alta del Paciente , Gestión de Riesgos , Humanos
3.
Ann Glob Health ; 87(1): 23, 2021 02 25.
Artículo en Inglés | MEDLINE | ID: mdl-33665145

RESUMEN

Introduction: Rwanda has made significant advancements in medical and economic development over the last 20 years and has emerged as a leader in healthcare in the East African region. The COVID-19 pandemic, which reached Rwanda in March 2020, presented new and unique challenges for infectious disease control. The objective of this paper is to characterize Rwanda's domestic response to the first year of the COVID-19 pandemic and highlight effective strategies so that other countries, including high and middle-income countries, can learn from its innovative initiatives. Methods: Government publications describing Rwanda's healthcare capacity were first consulted to obtain the country's baseline context. Next, official government and healthcare system communications, including case counts, prevention and screening protocols, treatment facility practices, and behavioral guidelines for the public, were read thoroughly to understand the course of the pandemic in Rwanda and the specific measures in the response. Results: As of 31 December 2020, Rwanda has recorded 8,383 cumulative COVID-19 cases, 6,542 recoveries, and 92 deaths since the first case on 14 March 2020. The Ministry of Health, Rwanda Biomedical Centre, and the Epidemic and Surveillance Response division have collaborated on preparative measures since the pandemic began in January 2020. The formation of a Joint Task Force in early March led to the Coronavirus National Preparedness and Response Plan, an extensive six-month plan that established a national incident management system and detailed four phases of a comprehensive national response. Notable strategies have included disseminating public information through drones, robots for screening and inpatient care, and official communications through social media platforms to combat misinformation and mobilize a cohesive response from the population. Conclusion: Rwanda's government and healthcare system has responded to the COVID-19 pandemic with innovative interventions to prevent and contain the virus. Importantly, the response has utilized adaptive and innovative technology and robust risk communication and community engagement to deliver an effective response to the COVID-19 pandemic.


Asunto(s)
Control de Enfermedades Transmisibles , Prestación de Atención de Salud , Regulación Gubernamental , Gestión de Riesgos , /epidemiología , Gestión del Cambio , Control de Enfermedades Transmisibles/legislación & jurisprudencia , Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/organización & administración , Comunicación , Prestación de Atención de Salud/organización & administración , Prestación de Atención de Salud/tendencias , Transmisión de Enfermedad Infecciosa/prevención & control , Humanos , Innovación Organizacional , Gestión de Riesgos/métodos , Gestión de Riesgos/organización & administración , Rwanda/epidemiología
4.
Soins ; 66(852): 50-52, 2021.
Artículo en Francés | MEDLINE | ID: mdl-33750561

RESUMEN

The presence of nurses within occupational health care teams is now mandatory. Their role, centred on prevention, health protection and employees' safety, is practised under the authority and in close collaboration with the occupational health doctor, within a multidisciplinary team. Over recent years, their scope of practice has been expanded to include the individual monitoring of employees' health. It could be further expanded in future.


Asunto(s)
Enfermería del Trabajo , Servicios de Salud del Trabajador , Humanos , Rol de la Enfermera , Servicios de Salud del Trabajador/organización & administración , Grupo de Atención al Paciente/organización & administración , Gestión de Riesgos/organización & administración
5.
Washington, D.C.; OPS; 2021-03-23. (OPS/HSS/MT/COVID-19/21-0003).
No convencional en Español | PAHO-IRIS | ID: phr-53362

RESUMEN

Las autoridades regulatorias nacionales (ARN) deben tomar decisiones sobre la autorización de uso de emergencia de una vacuna basándose en datos de seguridad y eficacia limitados. Por tanto, es necesario realizar un monitoreo constante una vez se autoriza su uso, a fin de detectar y evaluar posibles problemas de seguridad asociados a las vacunas aprobadas. Este documento tiene por objeto proporcionar recomendaciones y consideraciones que sirvan como guía para el desarrollo de estrategias de evaluación de los planes de gestión de riesgos y de los informes periódicos de seguridad de las vacunas solicitados como requisitos regulatorios para la autorización de uso de las vacunas contra la COVID-19, así como para el monitoreo de su seguridad una vez se autorice su uso. Está destinado principalmente a las ARN de la Región de las Américas y podría ser considerado por los titulares de la autorización de uso de las vacunas contra la COVID-19, para los fines de preparación de los planes e informes y su presentación ante las autoridades de salud.


Asunto(s)
Infecciones por Coronavirus , Sistemas de Salud , Servicios de Salud , Vacunas , Gestión de Riesgos
6.
Washington, D.C.; OPAS; 2021-03-02. (OPAS/IMS/FPL/COVID-19/21-0009).
en Portugués | PAHO-IRIS | ID: phr-53313

RESUMEN

Todos os países do mundo formularam planos de resposta para enfrentar a pandemia da COVID-19. No entanto, os desafios impostos pela doença os obrigam a aprender e adaptar-se constantemente. Cada vez mais é necessário reforçar o componente de comunicação de riscos como uma ferramenta essencial para transmitir à população, da devida forma, todas as informações sobre o processo de imunização, desde os testes clínicos e a produção de novas vacinas, até a adoção, distribuição e priorização dos grupos aos quais serão administradas uma ou mais vacinas — dependendo da definição e disponibilidade de cada país —, bem como sobre o acesso universal às vacinas, após os grupos prioritários terem sido imunizados. A Organização Pan-Americana da Saúde, em seu esforço constante e permanente para apoiar os países das Américas, apresenta este documento para facilitar a formulação de uma estratégia de comunicação de riscos e participação comunitária (CRPC) para a vacinação contra o SARS-CoV-2. O intuito é contribuir para o fortalecimento das capacidades de comunicação e planejamento dos ministérios e secretarias de saúde, bem como de outros órgãos responsáveis pela comunicação na área das novas vacinas contra a COVID-19 nas Américas.


Asunto(s)
Infecciones por Coronavirus , Infecciones por Coronavirus , Coronavirus , Inmunización , Guía , Comunicación , Gestión de Riesgos , Riesgo , Vacunas , Vacunación , Enfermedades Prevenibles por Vacunación
7.
Artículo en Inglés | MEDLINE | ID: mdl-33525331

RESUMEN

BACKGROUND: Effectively predicting and reducing readmission in long-term home care (LTHC) is challenging. We proposed, validated, and evaluated a risk management tool that stratifies LTHC patients by LACE predictive score for readmission risk, which can further help home care providers intervene with individualized preventive plans. METHOD: A before-and-after study was conducted by a LTHC unit in Taiwan. Patients with acute hospitalization within 30 days after discharge in the unit were enrolled as two cohorts (Pre-Implement cohort in 2017 and Post-Implement cohort in 2019). LACE score performance was evaluated by calibration and discrimination (AUC, area under receiver operator characteristic (ROC) curve). The clinical utility was evaluated by negative predictive value (NPV). RESULTS: There were 48 patients with 87 acute hospitalizations in Pre-Implement cohort, and 132 patients with 179 hospitalizations in Post-Implement cohort. These LTHC patients were of older age, mostly intubated, and had more comorbidities. There was a significant reduction in readmission rate by 44.7% (readmission rate 25.3% vs. 14.0% in both cohorts). Although LACE score predictive model still has room for improvement (AUC = 0.598), it showed the potential as a useful screening tool (NPV, 87.9%; 95% C.I., 74.2-94.8). The reduction effect is more pronounced in infection-related readmission. CONCLUSION: As real-world evidence, LACE score-based risk management tool significantly reduced readmission by 44.7% in this LTHC unit. Larger scale studies involving multiple homecare units are needed to assess the generalizability of this study.


Asunto(s)
Servicios de Atención de Salud a Domicilio , Readmisión del Paciente , Anciano , Servicio de Urgencia en Hospital , Humanos , Tiempo de Internación , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Gestión de Riesgos , Taiwán/epidemiología
8.
Artículo en Inglés | MEDLINE | ID: mdl-33562127

RESUMEN

The COVID-19 pandemic has been the largest global health crisis in decades. Apart from the unprecedented number of deaths and hospitalizations, the pandemic has resulted in economic slowdowns, widespread business disruptions, and significant hardships. This study focused on investigating the early impacts of the COVID-19 pandemic on the U.S. construction industry since the declaration of the national emergency on 13 March 2020. The study objectives were achieved through 34 telephone interviews with project managers, engineers, designers, and superintendents that represented different states and distinct industry sectors in the United States (U.S.). The interviewees offered information on their experience with the pandemic, including the general and adverse effects experienced, new opportunities created, and risk management efforts being undertaken. The reported adverse effects included significant delays on projects, inability to secure materials on time, reduction in productivity rates, material price escalations, and others. The new opportunities that were created included projects involving the fast-track construction of medical facilities, construction of residential buildings, transportation-related work, and opportunities to recruit skilled workers. The risk management measures that were widely adopted included measures to enhance safety and reduce other project risks. The safety measures adopted included requiring employees to wear cloth face masks, adoption of social distancing protocols, staggering of construction operations, offering COVID-19-related training, administering temperature checks prior to entry into the workplace, and others. Measures to manage other project risks included the formation of a task force team to review the evolving pandemic and offer recommendations, advocating that construction businesses be deemed essential to combat delays and taking advantage of government relief programs. The study findings will be useful to industry stakeholders interested in understanding the early impacts of the pandemic on the construction industry. Industry stakeholders may also build upon the reported findings and establish best practices for continued safe and productive operations.


Asunto(s)
/epidemiología , Industria de la Construcción/tendencias , Pandemias , /prevención & control , Control de Enfermedades Transmisibles , Humanos , Máscaras , Gestión de Riesgos , Estados Unidos/epidemiología
9.
Artículo en Inglés | MEDLINE | ID: mdl-33572570

RESUMEN

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease. Bilateral pneumonia, acute respiratory failure, systemic inflammation, endothelial dysfunction and coagulation activation are key features of severe COVID-19. Fibrinogen and D-dimer levels are typically increased. The risk for venous thromboembolism is markedly increased, especially in patients in the intensive care unit despite prophylactic dose anticoagulation. Pulmonary microvascular thrombosis has also been described and the risk for arterial thrombotic diseases also appears to be increased while bleeding is less common than thrombosis, but it can occur. Evaluation for venous thromboembolism may be challenging because symptoms of pulmonary embolism overlap with COVID-19, and imaging studies may not be feasible in all cases. The threshold for evaluation or diagnosis of thromboembolism should be low given the high frequency of these events. Management and treatment are new challenges due to the paucity of high-quality evidence regarding efficacy and safety of different approaches to prevent or treat thromboembolic complications of the disease. All inpatients should receive thromboprophylaxis unless contraindicated. Some institutional protocols provide more aggressive anticoagulation with intermediate or even therapeutic dose anticoagulation for COVID-19 patients admitted to ICU. Therapeutic dose anticoagulation is always appropriate to treat deep venous thrombosis or pulmonary embolism, unless contraindicated. This article reviews evaluation and management of coagulation abnormalities in individuals with COVID-19.


Asunto(s)
Trastornos de la Coagulación Sanguínea , Gestión de Riesgos , Tromboembolia Venosa , Anticoagulantes/uso terapéutico , Trastornos de la Coagulación Sanguínea/complicaciones , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico , Humanos , Tromboembolia Venosa/complicaciones , Tromboembolia Venosa/tratamiento farmacológico
10.
J Infect Public Health ; 14(3): 331-346, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33618278

RESUMEN

The recent emergence of novel coronavirus disease (COVID-19) triggered by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in substantial mortality worldwide. Presently, there is no approved treatment for COVID-19. Consequently, the clinical, scientific, and regulatory authorities have joint efforts to reduce the severe impact of COVID-19. To date, there is minimal arsenal with no definite curative drugs, licensed-vaccines, or therapeutic conducts to combat the COVID-19 infections. Keeping in view the threats of this pandemic, various global organizations, physicians, researchers, and scientists, are trying to recognize the epidemiological characteristics and pathogenic mechanisms of COVID-19 to discover potential treatment regimens, vaccines, and therapeutic modes for future anticipation. Herein, we summarize a contemporary overview of curative invasions and vaccines for COVID-19 based on the earlier information and considerate of similar earlier RNA coronaviruses. The information reviewed here establishes a paramount intellectual basis to promote ongoing research to develop vaccines and curative agents. Thus, this review suggests the furthermost accessible frontiers in the vaccine development to tackle or combat the COVID-19/SARS-CoV-2.


Asunto(s)
/tratamiento farmacológico , Gestión de Riesgos , Antivirales/uso terapéutico , Humanos , Masculino , Estudios Multicéntricos como Asunto , Pandemias , Ensayos Clínicos Controlados Aleatorios como Asunto
11.
Trials ; 22(1): 117, 2021 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-33546716

RESUMEN

This article describes how one trial site of the Refugee Emergency: Defining and Implementing Novel Evidence-based psychosocial interventions (RE-DEFINE) study, designed to evaluate a Self Help+ intervention with Arabic-speaking refugees and asylum seekers currently living in the UK and experiencing stress, was adapted to accommodate social distancing rules and working from home during the COVID-19 restrictions. Digital divide, risk and safety management, acceptability of remote data collection and practical considerations are described. The adaptions to methods have practical implications for researchers looking for more flexible approaches in response to continuing restrictions resulting from COVID-19, and the authors believe that others could adopt such an approach. The need for a further acceptability study focusing on human and economic costs and benefits of telephone and video as an alternative to face-to-face data collection is indicated. TRIALS REGISTRATION: Refugee Emergency - Defining and Implementing Novel Evidence-based psychosocial interventions RE-DEFINE. (Trials registration numbers NCT03571347 , NCT03587896 ) https://doi.org/10.1136/bmjopen-2019-030259 (2019).


Asunto(s)
/complicaciones , Recolección de Datos/métodos , Pandemias , Cuarentena/psicología , Refugiados/psicología , Árabes/psicología , /etnología , /virología , Estudios de Seguimiento , Encuestas Epidemiológicas , Humanos , Gestión de Riesgos , Teléfono , Reino Unido/epidemiología
12.
Washington, D.C.; OPS; 2021-02-11. (OPS/IMS/FPL/COVID-19/21-0009).
en Español | PAHO-IRIS | ID: phr-53259

RESUMEN

Todos los países del mundo han desarrollado planes de respuesta para enfrentar la pandemia de COVID-19; sin embargo, los desafíos que presenta la enfermedad los obliga a un aprendizaje y a una adaptación constantes. Cada vez es más necesario reforzar el componente de comunicación de riesgos como herramienta esencial para transmitir de forma adecuada a la población toda la información sobre el proceso de inmunización, desde los ensayos clínicos y la producción de nuevas vacunas, hasta la introducción, distribución y priorización de grupos a los que hay que administrar una o varias vacunas —según la definición y la disponibilidad de cada país— así como el acceso universal a ellas, una vez inmunizados los grupos prioritarios. La OPS, dentro de su empeño constante por apoyar a los países de las Américas, publica el presente documento con ánimo de facilitar la elaboración de una estrategia de comunicación de riesgos y participación comunitaria para la vacunación contra la COVID-19. Su finalidad es contribuir a fortalecer las capacidades y la planificación de la comunicación de los ministerios o secretarías de salud, así como de otros organismos encargados de comunicar en el área de las nuevas vacunas contra la COVID-19 en las Américas.


Asunto(s)
Infecciones por Coronavirus , Inmunización , Guía , Coronavirus , Infecciones por Coronavirus , Comunicación , Gestión de Riesgos , Riesgo , Betacoronavirus , Vacunación , Vacunas , Enfermedades Prevenibles por Vacunación
13.
Artículo en Inglés | MEDLINE | ID: mdl-33445712

RESUMEN

Prevention of post-traumatic stress symptoms (PTSS) in healthcare workers (HCWs) facing the current COVID-19 pandemic is a challenge worldwide as HCWs are likely to experience acute and chronic, often unpredictable, occupational stressors leading to PTSS. This review aims to analyze the literature to discover which topics have been focused on and what the latest developments are in managing the occupational risk of PTSS in HCWs during the current pandemic. For the purpose of this review, we searched for publications in MEDLINE/Pubmed using selected keywords. The articles were reviewed and categorized into one or more of the following categories based on their subject matter: risk assessment, risk management, occurrence rates. A total of 16 publications matched our inclusion criteria. The topics discussed were: "Risk Assessment", "Occurrence Rates", and "Risk Management". Young age, low work experience, female gender, heavy workload, working in unsafe settings, and lack of training and social support were found to be predictors of PTSS. This review's findings showed the need for urgent interventions aimed at protecting HCWs from the psychological impact of traumatic events related to the pandemic and leading to PTSS; healthcare policies need to consider preventive and management strategies toward PTSS, and the related psychic sequelae, in HCWs.


Asunto(s)
/psicología , Personal de Salud/psicología , Exposición Profesional/efectos adversos , Trastornos por Estrés Postraumático/psicología , Humanos , Pandemias , Medición de Riesgo , Gestión de Riesgos , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/etiología
14.
Chirurg ; 92(3): 232-236, 2021 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-33427894

RESUMEN

The management of errors and complications makes a significant contribution to the quality assurance of a surgical department. The structured risk management is an integral component of the surgeon's duties that is reflected by the growing relevance of simulation and other training methods employed during medical specialist advanced training. Basic prerequisites for establishing an error culture that aims at improvement of patient safety and the constructive coping with complications, are the removal of taboos and the transparent processing of complicating courses of treatment. Detecting structural and systemic sources of error is preferrable to the application of approaches that focus on individual responsibility, e.g. shame and blame. There are numerous validated tools available for the prevention, recognition and successful treatment of complications. Team time out protocols for circumventing fatal errors, standardized operating procedures and morbidity and mortality conferences are the most important measures for ensuring patient safety. The standardized, consistent and interdisciplinary handling of unavoidable complications according to the failure to rescue concept is pivotal for the prevention of a fatal course.


Asunto(s)
Seguridad del Paciente , Gestión de Riesgos , Humanos , Errores Médicos/prevención & control
15.
PLoS One ; 16(1): e0244706, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33406106

RESUMEN

Without vaccines and treatments, societies must rely on non-pharmaceutical intervention strategies to control the spread of emerging diseases such as COVID-19. Though complete lockdown is epidemiologically effective, because it eliminates infectious contacts, it comes with significant costs. Several recent studies have suggested that a plausible compromise strategy for minimizing epidemic risk is periodic closure, in which populations oscillate between wide-spread social restrictions and relaxation. However, no underlying theory has been proposed to predict and explain optimal closure periods as a function of epidemiological and social parameters. In this work we develop such an analytical theory for SEIR-like model diseases, showing how characteristic closure periods emerge that minimize the total outbreak, and increase predictably with the reproductive number and incubation periods of a disease- as long as both are within predictable limits. Using our approach we demonstrate a sweet-spot effect in which optimal periodic closure is maximally effective for diseases with similar incubation and recovery periods. Our results compare well to numerical simulations, including in COVID-19 models where infectivity and recovery show significant variation.


Asunto(s)
Brotes de Enfermedades/prevención & control , Cuarentena/métodos , Gestión de Riesgos/métodos , /prevención & control , Control de Enfermedades Transmisibles/métodos , Enfermedades Transmisibles/psicología , Brotes de Enfermedades/estadística & datos numéricos , Epidemias/prevención & control , Epidemias/estadística & datos numéricos , Humanos , Modelos Teóricos , /patogenicidad
16.
Aerosp Med Hum Perform ; 92(2): 127-128, 2021 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-33468295

RESUMEN

INTRODUCTION: Noninferiority or equivalence testing are often used when comparing a novel pharmaceutical, operation, or procedure to the current standard designated as safe. Noninferiority and equivalence testing require estimates of a metric called delta: the margin of meaningful difference. Inappropriate delta margins can lead to invalid conclusions, thereby creating uncertainty about a studys scientific credibility. We recommend that a working group be convened with the following goals: 1) to evaluate delta values currently in use in aviation; 2) to determine if it is possible to develop a systematic, evidence-based, and replicable process to derive delta values based on statistical properties from population data, rather than a mixture of evidence- and opinion-based processes; and 3) based on the findings of the second goal, update the current delta values in use in aviation. This working group should include, at a minimum, government agencies and other key stakeholders using these values within operational settings.Lamp ACM, Rempe MJ, Belenky GL. Delta: the value that matters in fatigue risk management. Aerosp Med Hum Perform. 2021; 92(2):127128.


Asunto(s)
Aviación/estadística & datos numéricos , Fatiga , Gestión de Riesgos/estadística & datos numéricos , Administración de la Seguridad , Humanos
20.
Int J Qual Health Care ; 33(1)2021 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-33313653

RESUMEN

BACKGROUND: The dissemination of scientific data on coronavirus disease 2019 (COVID-19) continually builds but, in April 2020, could not keep up with the spread of the disease. Through technology, surgeons in Italy and the UK, representing both peak and pre-peak infective time zones, were able to communicate so that the urgent lessons on the huge expected demands of care learned in Italy could be brought to the UK in advance. This paper specifically discusses the issues related to paediatric surgery, currently under-reported in the literature. METHODS: The aim of this paper is to conjoin experience from the field to provide a framework for a safe assessment and treatment of paediatric patients by adopting a systemic approach aimed at reducing the risk of contamination. We reviewed the processes and good practices that were undertaken in contexts of emergency such as in Italy and the UK and then adapted them within the Systems Engineering Initiative for Patient Safety (SEIPS) framework to provide an assessment of how to reorganize the services in order to cope with an unexpected situation. The SEIPS model is the adopted theoretical framework, which allows to analyse the system in its main components with a human factors and ergonomics (HFE) perspective. RESULTS: The results introduce some of the good practices and recommendations developed during the emergency in the surgical scenario with a focus on the paediatric patients. They represent the lessons learned from the combination of the little existing evidence of literature and the experience from surgical teams who responded in an impromptu and unrehearsed way. CONCLUSIONS: Lessons learned from the frontline 'on the fly' during COVID-19 emergency should be consolidated and taken into the future. In order to prepare proactively for the next phases and get ahead of the curve of these hospital accesses, there is a need for a risk assessment of the new clinical pathways with a multidisciplinary approach centred on HFE with the adoption of the SEIPS model and an involvement of all the surgical teams.


Asunto(s)
/epidemiología , Control de Infecciones/métodos , Seguridad del Paciente , Procedimientos Quirúrgicos Operativos , Niño , Ergonomía , Humanos , Italia/epidemiología , Modelos Teóricos , Gestión de Riesgos , Reino Unido/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...